Core Points - Radiance Biopharma has been selected to participate in the Seed Showcase at Biotech Showcase™ 2025, indicating recognition and potential growth opportunities for the company [1][2] - The company focuses on developing next-generation Antibody Drug Conjugates (ADCs) and Bispecific ADCs (BsADCs) for cancer treatment, highlighting its commitment to innovative cancer therapeutics [4] Event Details - The presentation is scheduled for January 15, 2025, at 2:10 PM PT, in the Franciscan B track at the Hilton San Francisco - Union Square [3] - Biotech Showcase™ is a well-established conference that provides a platform for networking, workshops, and one-to-one meetings, enhancing visibility for participating companies [3] Company Overview - Radiance Biopharma is dedicated to developing a pipeline of antibody-based cancer therapeutics, focusing on both mono and bispecific ADCs [4]
Radiance has been selected to Present at the 2025 Biotech Showcase™ Alongside the J.P. Morgan Healthcare Conference
Globenewswire·2025-01-15 21:50